LONG TERM EFFICACY OF INFLIXIMAB IN INFLAMMATORY BOWEL DISEASE AT A SINGLE TERTIARY CENTER

被引：0
|
作者：
Nuti, F. [1 ]
Conte, F. [1 ]
Cavallari, N. [1 ]
Civitelli, F. [1 ]
Aloi, M. [1 ]
Del Giudice, E. [1 ]
Pannone, V. [1 ]
Di Nardo, G. [1 ]
Cucchiara, S. [1 ]
Viola, F. [1 ]
机构：
[1] Univ Roma La Sapienza, Pediat Gastroenterol & Liver Unit, Rome, Italy
来源：
JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION | 2010年 / 50卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：E108 / E108
页数：1
相关论文
共 50 条
  • [41] Long-Term Outcome of Infliximab Optimization for Overcoming Immunogenicity in Patients with Inflammatory Bowel Disease
    Konstantinos Papamichael
    Ravy K. Vajravelu
    Mark T. Osterman
    Adam S. Cheifetz
    Digestive Diseases and Sciences, 2018, 63 : 761 - 767
  • [42] Long-term clinical outcome after infliximab discontinuation in patients with inflammatory bowel disease
    Lee, Ji Min
    Kim, Yoon Jae
    Lee, Kang-Moon
    Yoon, Hyuk
    Lee, Bo-In
    Kim, Dae Bum
    Kang, Donghoon
    SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 2018, 53 (10-11) : 1280 - 1285
  • [43] Infliximab trough levels for remission induction and long term therapy management of inflammatory bowel disease
    Perdigoto, D.
    Portela, F.
    Ferreira, M.
    Mendes, S.
    Freire, P.
    Ferreira, M.
    Lopes, S.
    Tome, L.
    JOURNAL OF CROHNS & COLITIS, 2017, 11 : S386 - S386
  • [44] Comparison of efficacy and safety of biosimilar infliximab to originator infliximab in children with inflammatory bowel disease
    Muhammed, R.
    Whyte, L.
    Protheroe, S.
    Bremner, R.
    Haller, W.
    Wong, T.
    JOURNAL OF CROHNS & COLITIS, 2016, 10 : S291 - S291
  • [45] Experience using infliximab for Crohn Disease at a pediatric inflammatory bowel disease center
    Stephens, MC
    Shepanski, MA
    Mamula, P
    Markowitz, JE
    Brown, K
    Hurd, LB
    Piccoli, DA
    Baldassano, RN
    GASTROENTEROLOGY, 2002, 122 (04) : A12 - A12
  • [46] COMPARISON OF EFFICACY AND SAFETY OF BIOSIMILAR INFLIXIMAB TO ORIGINATOR INFLIXIMAB IN CHILDREN WITH INFLAMMATORY BOWEL DISEASE
    Muhammed, R.
    Wong, T.
    Haller, W.
    Protheroe, S.
    Whyte, L.
    Bremner, R.
    GUT, 2016, 65 : A259 - A260
  • [47] Long-term safety of azathioprine treatment in inflammatory bowel disease: Results from a single referral center
    Katsanos, Konstantinos
    Ferrante, Marc
    Fidder, Herma
    Henckaerts, Liesbet
    Christodoulou, Dimitrios
    Van assche, Gert A.
    Tsianos, Epameinondas V.
    Vermeire, Severine
    Rutgeerts, Paul
    GASTROENTEROLOGY, 2007, 132 (04) : A652 - A652
  • [48] PREVALENCE AND CHARACTERISTICS OF CHRONIC KIDNEY DISEASE IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE: TERTIARY SINGLE CENTER EXPERIENCE
    Konda, Raghunandan
    Beasley, Mark
    Shipley, Lindsey C.
    Patel, Parth B.
    Russ, Kirk B.
    Rizk, Dana, V
    AMERICAN JOURNAL OF KIDNEY DISEASES, 2025, 85 (04)
  • [49] Prevalence and characteristics of chronic kidney disease in patients with inflammatory bowel disease: tertiary single center experience
    Konda, R.
    Beasley, M.
    Shipley, L. C.
    Patel, P. B.
    Russ, K. B.
    Rizk, D.
    AMERICAN JOURNAL OF THE MEDICAL SCIENCES, 2025, 369
  • [50] Biologic Treatment Modification Efficacy in Concurrent Inflammatory Bowel Disease and Ankylosing Spondylitis: A Retrospective Cohort Study at a Single Tertiary Center
    Savin, Einat
    Ben-Shabat, Niv
    Levartovsky, Asaf
    Lahat, Adi
    Omar, Mahmud
    Gendelman, Omer
    Lidar, Merav
    Watad, Abdulla
    Ben-Horin, Shomron
    Kopylov, Uri
    Sharif, Kassem
    JOURNAL OF CLINICAL MEDICINE, 2023, 12 (22)
12345